Pure Global
NCT02653066

HealtheRx Survey for Pulmonary Research Registry Recruitment

University of Chicago·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Asthma,COPD
Drug/Device/Intervention
HealtheRx+
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Chicago
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2015
End date
Dec 01, 2019
Enrollment
41 participants
Primary outcome

Cost per consented subject

Summary

The purpose of this research is to study the utility of using the HealtheRx as a tool to
 recruit eligible patients into the Pulmonary Research Registry (PRR) (IRB 15543B) at the
 University of Chicago. HealtheRx is an example of a potential recruitment tool that has high
 reach in populations typically underrepresented in research studies, uses a high tech
 infrastructure that allows matching of research opportunities to patient characteristics, but
 that delivers information in a low-tech, patient-centered mode using the printed HealtheRx
 prescription.

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaOther chronic obstructive pulmonary disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT02653066
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT02653066 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Chicago and is currently Completed. The study focuses on Asthma,COPD. Target enrollment is 41 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.